Report
EUR 14.32 For Business Accounts Only

With a more favourable environment, ODONTOPREV ON improves to Positive

ODONTOPREV ON (BR), a company active in the Health Care Providers industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 2 out of 4 stars, as well as its unchanged, defensive market behaviour. The title leverages a more favourable environment and raises its general evaluation to Positive. As of the analysis date December 17, 2021, the closing price was BRL 12.02 and its potential was estimated at BRL 15.12.
Underlying
OdontoPrev S.A.

Odontoprev is a dental benefits company based in Brazil. Co. is engaged in the provision of dental assistance services plan, including the administration and commercialization of services to private companies. Co. develops customized dental plans for a wide variety of corporate clients, labor unions, insurance companies, and associations. Co.'s network includes approximately 25,000 certified dentists, of which approximately 16,000 are specialists and post-graduates, located in around 2,000 cities throughout Brazil. Co. is also engaged in the participation of other companies as a partner and/or shareholder.

Provider
TheScreener
TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals.  Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

  • Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization.  theScreener state of art: We provide
  • theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
  • For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded

 

Other Reports on these Companies
Other Reports from TheScreener

ResearchPool Subscriptions

Get the most out of your insights

Get in touch